Back to results
US 2016/0106829 A1Published application
Attenuated vaccinia virus kvac103 strain
AssigneeKorea Centers for Disease Control and Prevention
InventorsSang Gu Yeo, Ho Sun Son, June Woo Lee, Seung Bin Cha, Sun Hwa Lee, Kwi Sung Park
Life of this patent
Estimating the term…
Abstract
Disclosed herein is the attenuated vaccinia virus strain KVAC103 obtained by subculturing a vaccinia virus strain 103 times in VERO cells. The attenuated vaccinia virus strain KVAC103 has significantly low toxicity, shows reduced skin lesions, and, at the same time, induces effectively immune responses to poxvirus. Thus, it can be used as a poxvirus vaccine while causing less side effects.
Claims10
Attenuated vaccinia virus strain KVAC103 (accession No. KCCM11574P).
Dependencies are inferred from the claim text.